Differentiation Signaling in Prostate Stem Cells View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2011-2017

FUNDING AMOUNT

1918959 USD

ABSTRACT

DESCRIPTION: Prostate stem cells maintain self-renewal and inhibit differentiation to remain in the stem cell state. In the prostate the mechanisms required to maintain stem cell properties can be therapeutically targeted to eliminate the stem cell compartment to reduce the number of new cells. Our long-term goal is to understand how an unregulated stem cell compartment contributes to prostatic diseases and determine if they can be a therapeutically targeted. The ABC transporters protect stem cells from xenobiotics. Prostate and hematopoietic stem cells can be enriched based on the high efflux capacity of Hoechst dye, defined as the side population. The ABC transporter ABCG2, is required for the side population phenotype. While it has long been appreciated that the side population is enriched for stem cells, and ABCG2 is required for the side population, it is unknown if ABCG2 function maintaining the stem cell state. Our data suggests ABCG2 effluxes androgen. The overall objective of this proposal is to determine whether the inhibition of ABCG2 can force accumulation of androgen resulting in stem cell differentiation. The central hypothesis is that ABCG2 efflux of androgen inhibits prostate stem cell differentiation to maintain stem cell properties. The rationale for the proposed research is to determine whether forcing prostate stem cells to differentiate is a therapeutic option for prostatic diseases that are caused by an unregulated stem cell niche including benign prostatic hyperplasia (BPH). The hypothesis is tested in three specific aims: 1. Determine the mechanism of androgen efflux to maintain stem cell properties. 2. Identify regulators of the side population phenotype that contribute to maintaining prostate stem cell properties. 3. Determine the effect of abrogated ABCG2 function on the prostate stem cell niche. The proposed studies are anticipated to demonstrate that: ABCG2 mediated androgen efflux inhibits AR induced prostate stem cell differentiation; Prostate stem cells within the side population require ABCG2 expression; and ABCG2 inhibition depletes stem cell compartment and the prostate is unable to serially regenerate. This contribution is significant because the proposed studies seek to determine whether prostate stem cells can be eliminated by inhibition of ABCG2 function. The research described in this proposal is innovative because we are functionally targeting the biology of the stem cell without the necessity of identifying prostate stem cell markers. Thus, this proposal exploits the biology of the phenotype of the prostate stem cell. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=8899342

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2206", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "USD", 
      "type": "MonetaryAmount", 
      "value": "1918959"
    }, 
    "description": "DESCRIPTION: Prostate stem cells maintain self-renewal and inhibit differentiation to remain in the stem cell state. In the prostate the mechanisms required to maintain stem cell properties can be therapeutically targeted to eliminate the stem cell compartment to reduce the number of new cells. Our long-term goal is to understand how an unregulated stem cell compartment contributes to prostatic diseases and determine if they can be a therapeutically targeted. The ABC transporters protect stem cells from xenobiotics. Prostate and hematopoietic stem cells can be enriched based on the high efflux capacity of Hoechst dye, defined as the side population. The ABC transporter ABCG2, is required for the side population phenotype. While it has long been appreciated that the side population is enriched for stem cells, and ABCG2 is required for the side population, it is unknown if ABCG2 function maintaining the stem cell state. Our data suggests ABCG2 effluxes androgen. The overall objective of this proposal is to determine whether the inhibition of ABCG2 can force accumulation of androgen resulting in stem cell differentiation. The central hypothesis is that ABCG2 efflux of androgen inhibits prostate stem cell differentiation to maintain stem cell properties. The rationale for the proposed research is to determine whether forcing prostate stem cells to differentiate is a therapeutic option for prostatic diseases that are caused by an unregulated stem cell niche including benign prostatic hyperplasia (BPH). The hypothesis is tested in three specific aims: 1. Determine the mechanism of androgen efflux to maintain stem cell properties. 2. Identify regulators of the side population phenotype that contribute to maintaining prostate stem cell properties. 3. Determine the effect of abrogated ABCG2 function on the prostate stem cell niche. The proposed studies are anticipated to demonstrate that: ABCG2 mediated androgen efflux inhibits AR induced prostate stem cell differentiation; Prostate stem cells within the side population require ABCG2 expression; and ABCG2 inhibition depletes stem cell compartment and the prostate is unable to serially regenerate. This contribution is significant because the proposed studies seek to determine whether prostate stem cells can be eliminated by inhibition of ABCG2 function. The research described in this proposal is innovative because we are functionally targeting the biology of the stem cell without the necessity of identifying prostate stem cell markers. Thus, this proposal exploits the biology of the phenotype of the prostate stem cell.", 
    "endDate": "2017-07-31T00:00:00Z", 
    "funder": {
      "id": "https://www.grid.ac/institutes/grid.419635.c", 
      "type": "Organization"
    }, 
    "id": "sg:grant.2500346", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "2500346"
        ]
      }, 
      {
        "name": "nih_id", 
        "type": "PropertyValue", 
        "value": [
          "R01DK091240"
        ]
      }
    ], 
    "inLanguage": [
      "en"
    ], 
    "keywords": [
      "phenotype", 
      "new cells", 
      "long-term goal", 
      "number", 
      "ABCG2 effluxes androgen", 
      "differentiation", 
      "benign prostatic hyperplasia", 
      "androgens", 
      "prostate stem cell properties", 
      "stem cell state", 
      "stem cell compartment", 
      "prostate", 
      "stem cell properties", 
      "proposal", 
      "unregulated stem cell niche", 
      "ABCG2 efflux", 
      "ABCG2 expression", 
      "necessity", 
      "Prostate Stem Cells", 
      "self-renewal", 
      "accumulation", 
      "study", 
      "unregulated stem cell compartment", 
      "regulators", 
      "prostate stem cell differentiation", 
      "xenobiotics", 
      "Hoechst dye", 
      "cell compartment", 
      "side population", 
      "data", 
      "effect", 
      "ABCG2 inhibition", 
      "prostatic diseases", 
      "hematopoietic stem cells", 
      "stem cell differentiation", 
      "contribution", 
      "hypothesis", 
      "inhibition", 
      "Ar", 
      "side population phenotype", 
      "ABC transporter ABCG2", 
      "androgen efflux", 
      "high efflux capacity", 
      "stem cells", 
      "prostate stem cells", 
      "specific aim", 
      "function", 
      "prostate stem cell niche", 
      "ABCG2", 
      "therapeutic options", 
      "biology", 
      "mechanism", 
      "description", 
      "research", 
      "ABC transporters", 
      "ABCG2 function", 
      "overall objective", 
      "rationale", 
      "central hypothesis", 
      "prostate stem cell markers"
    ], 
    "name": "Differentiation Signaling in Prostate Stem Cells", 
    "recipient": [
      {
        "id": "https://www.grid.ac/institutes/grid.240614.5", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "https://www.grid.ac/institutes/grid.240614.5", 
          "name": "ROSWELL PARK CANCER INSTITUTE CORP", 
          "type": "Organization"
        }, 
        "familyName": "HUSS", 
        "givenName": "WENDY JOY", 
        "id": "sg:person.01106345252.27", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.01106345252.27", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.2500346"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2019-03-07T12:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_8.xml.gz", 
    "startDate": "2011-08-01T00:00:00Z", 
    "type": "MonetaryGrant", 
    "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=8899342"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2500346'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2500346'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2500346'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2500346'


 

This table displays all metadata directly associated to this object as RDF triples.

104 TRIPLES      19 PREDICATES      82 URIs      74 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:grant.2500346 schema:about anzsrc-for:2206
2 schema:amount N4824e7f168e941f39f3613eed958ec5c
3 schema:description DESCRIPTION: Prostate stem cells maintain self-renewal and inhibit differentiation to remain in the stem cell state. In the prostate the mechanisms required to maintain stem cell properties can be therapeutically targeted to eliminate the stem cell compartment to reduce the number of new cells. Our long-term goal is to understand how an unregulated stem cell compartment contributes to prostatic diseases and determine if they can be a therapeutically targeted. The ABC transporters protect stem cells from xenobiotics. Prostate and hematopoietic stem cells can be enriched based on the high efflux capacity of Hoechst dye, defined as the side population. The ABC transporter ABCG2, is required for the side population phenotype. While it has long been appreciated that the side population is enriched for stem cells, and ABCG2 is required for the side population, it is unknown if ABCG2 function maintaining the stem cell state. Our data suggests ABCG2 effluxes androgen. The overall objective of this proposal is to determine whether the inhibition of ABCG2 can force accumulation of androgen resulting in stem cell differentiation. The central hypothesis is that ABCG2 efflux of androgen inhibits prostate stem cell differentiation to maintain stem cell properties. The rationale for the proposed research is to determine whether forcing prostate stem cells to differentiate is a therapeutic option for prostatic diseases that are caused by an unregulated stem cell niche including benign prostatic hyperplasia (BPH). The hypothesis is tested in three specific aims: 1. Determine the mechanism of androgen efflux to maintain stem cell properties. 2. Identify regulators of the side population phenotype that contribute to maintaining prostate stem cell properties. 3. Determine the effect of abrogated ABCG2 function on the prostate stem cell niche. The proposed studies are anticipated to demonstrate that: ABCG2 mediated androgen efflux inhibits AR induced prostate stem cell differentiation; Prostate stem cells within the side population require ABCG2 expression; and ABCG2 inhibition depletes stem cell compartment and the prostate is unable to serially regenerate. This contribution is significant because the proposed studies seek to determine whether prostate stem cells can be eliminated by inhibition of ABCG2 function. The research described in this proposal is innovative because we are functionally targeting the biology of the stem cell without the necessity of identifying prostate stem cell markers. Thus, this proposal exploits the biology of the phenotype of the prostate stem cell.
4 schema:endDate 2017-07-31T00:00:00Z
5 schema:funder https://www.grid.ac/institutes/grid.419635.c
6 schema:identifier N50dd2e22da694bceb69762e1040c8ae8
7 Ncf7ae85ca68946e2857455efd27cd90c
8 schema:inLanguage en
9 schema:keywords ABC transporter ABCG2
10 ABC transporters
11 ABCG2
12 ABCG2 efflux
13 ABCG2 effluxes androgen
14 ABCG2 expression
15 ABCG2 function
16 ABCG2 inhibition
17 Ar
18 Hoechst dye
19 Prostate Stem Cells
20 accumulation
21 androgen efflux
22 androgens
23 benign prostatic hyperplasia
24 biology
25 cell compartment
26 central hypothesis
27 contribution
28 data
29 description
30 differentiation
31 effect
32 function
33 hematopoietic stem cells
34 high efflux capacity
35 hypothesis
36 inhibition
37 long-term goal
38 mechanism
39 necessity
40 new cells
41 number
42 overall objective
43 phenotype
44 proposal
45 prostate
46 prostate stem cell differentiation
47 prostate stem cell markers
48 prostate stem cell niche
49 prostate stem cell properties
50 prostate stem cells
51 prostatic diseases
52 rationale
53 regulators
54 research
55 self-renewal
56 side population
57 side population phenotype
58 specific aim
59 stem cell compartment
60 stem cell differentiation
61 stem cell properties
62 stem cell state
63 stem cells
64 study
65 therapeutic options
66 unregulated stem cell compartment
67 unregulated stem cell niche
68 xenobiotics
69 schema:name Differentiation Signaling in Prostate Stem Cells
70 schema:recipient N8f006047d5374c3780e038a6271888b4
71 sg:person.01106345252.27
72 https://www.grid.ac/institutes/grid.240614.5
73 schema:sameAs https://app.dimensions.ai/details/grant/grant.2500346
74 schema:sdDatePublished 2019-03-07T12:16
75 schema:sdLicense https://scigraph.springernature.com/explorer/license/
76 schema:sdPublisher Nd3027dc77b5a423fac3d4d1af152d030
77 schema:startDate 2011-08-01T00:00:00Z
78 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=8899342
79 sgo:license sg:explorer/license/
80 sgo:sdDataset grants
81 rdf:type schema:MonetaryGrant
82 N4824e7f168e941f39f3613eed958ec5c schema:currency USD
83 schema:value 1918959
84 rdf:type schema:MonetaryAmount
85 N50dd2e22da694bceb69762e1040c8ae8 schema:name dimensions_id
86 schema:value 2500346
87 rdf:type schema:PropertyValue
88 N8f006047d5374c3780e038a6271888b4 schema:member sg:person.01106345252.27
89 schema:roleName PI
90 rdf:type schema:Role
91 Ncf7ae85ca68946e2857455efd27cd90c schema:name nih_id
92 schema:value R01DK091240
93 rdf:type schema:PropertyValue
94 Nd3027dc77b5a423fac3d4d1af152d030 schema:name Springer Nature - SN SciGraph project
95 rdf:type schema:Organization
96 anzsrc-for:2206 schema:inDefinedTermSet anzsrc-for:
97 rdf:type schema:DefinedTerm
98 sg:person.01106345252.27 schema:affiliation https://www.grid.ac/institutes/grid.240614.5
99 schema:familyName HUSS
100 schema:givenName WENDY JOY
101 rdf:type schema:Person
102 https://www.grid.ac/institutes/grid.240614.5 schema:name ROSWELL PARK CANCER INSTITUTE CORP
103 rdf:type schema:Organization
104 https://www.grid.ac/institutes/grid.419635.c schema:Organization
 




Preview window. Press ESC to close (or click here)


...